Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rothenberg

Showing results (391-400 of 658) with videos related to

Pageof 66
Sort By:
Clinical and Translational Science|May 17, 2026
Collaboration as a Catalyst for Advancing Rare Disease Research: The Experience of the Rare Diseases Clinical Research NetworkMirna Chehade, Sheridan Meyers, Talaya McCright-Gill, et al.
Immunology and Cell Biology|November 3, 1998
Cellular and molecular regulation of eosinophil trafficking to the lungS P Hogan, A W Mould, J M Young, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2015
TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitisAdam M Collison, Leon A Sokulsky, Joseph D Sherrill, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 29, 2018
MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunctionMaryam Syed, Jana P Ball, Keisa W Mathis, et al.
Clinical Drug Investigation|July 25, 2019
Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na<sub>V</sub>1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy VolunteersMichael E Rothenberg, Michael Tagen, Jae H Chang, et al.
Annual Review of Immunology|March 1, 2021
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological TherapiesElizabeth A Jacobsen, David J Jackson, Enrico Heffler, et al.
BMC Gastroenterology|November 22, 2011
Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methodsJames P Franciosi, Kevin A Hommel, Charles W DeBrosse, et al.
Clinical Drug Investigation|June 8, 2019
Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na<sub>V</sub>1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy VolunteersMichael E Rothenberg, Michael Tagen, Jae H Chang, et al.
Environmental Health : a Global Access Science Source|April 29, 2021
Maternal methylmercury exposure through rice ingestion and child neurodevelopment in the first three years: a prospective cohort study in rural ChinaSarah E Rothenberg, Susan A Korrick, Jihong Liu, et al.
Frontiers in Microbiology|June 28, 2021
Fecal Methylmercury Correlates With Gut Microbiota Taxa in Pacific Walruses (<i>Odobenus rosmarus divergens</i>)Sarah E Rothenberg, Danielle N Sweitzer, Bryna R Rackerby, et al.
Pageof 66

Showing results (391-400 of 658) with videos related to

Sort By:
Pageof 66
Clinical and Translational Science|May 17, 2026
Collaboration as a Catalyst for Advancing Rare Disease Research: The Experience of the Rare Diseases Clinical Research NetworkMirna Chehade, Sheridan Meyers, Talaya McCright-Gill, et al.
Immunology and Cell Biology|November 3, 1998
Cellular and molecular regulation of eosinophil trafficking to the lungS P Hogan, A W Mould, J M Young, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2015
TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitisAdam M Collison, Leon A Sokulsky, Joseph D Sherrill, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 29, 2018
MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunctionMaryam Syed, Jana P Ball, Keisa W Mathis, et al.
Clinical Drug Investigation|July 25, 2019
Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na<sub>V</sub>1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy VolunteersMichael E Rothenberg, Michael Tagen, Jae H Chang, et al.
Annual Review of Immunology|March 1, 2021
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological TherapiesElizabeth A Jacobsen, David J Jackson, Enrico Heffler, et al.
BMC Gastroenterology|November 22, 2011
Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methodsJames P Franciosi, Kevin A Hommel, Charles W DeBrosse, et al.
Clinical Drug Investigation|June 8, 2019
Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na<sub>V</sub>1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy VolunteersMichael E Rothenberg, Michael Tagen, Jae H Chang, et al.
Environmental Health : a Global Access Science Source|April 29, 2021
Maternal methylmercury exposure through rice ingestion and child neurodevelopment in the first three years: a prospective cohort study in rural ChinaSarah E Rothenberg, Susan A Korrick, Jihong Liu, et al.
Frontiers in Microbiology|June 28, 2021
Fecal Methylmercury Correlates With Gut Microbiota Taxa in Pacific Walruses (<i>Odobenus rosmarus divergens</i>)Sarah E Rothenberg, Danielle N Sweitzer, Bryna R Rackerby, et al.
Pageof 66